255 related articles for article (PubMed ID: 15039137)
1. Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma.
Marc MM; Korosec P; Kosnik M; Kern I; Flezar M; Suskovic S; Sorli J
Am J Respir Cell Mol Biol; 2004 Aug; 31(2):216-9. PubMed ID: 15039137
[TBL] [Abstract][Full Text] [Related]
2. Complement factor C5a in acute exacerbation of Chronic Obstructive Pulmonary Disease.
Marc MM; Kristan SS; Rozman A; Kern I; Flezar M; Kosnik M; Korosec P
Scand J Immunol; 2010 May; 71(5):386-91. PubMed ID: 20500690
[TBL] [Abstract][Full Text] [Related]
3. Purification and functional assessment of C3a, C4a and C5a of the common carp (Cyprinus carpio) complement.
Kato Y; Nakao M; Shimizu M; Wariishi H; Yano T
Dev Comp Immunol; 2004 Jul; 28(9):901-10. PubMed ID: 15183031
[TBL] [Abstract][Full Text] [Related]
4. [Changes of anaphylatoxin C5a in chronic obstructive pulmonary disease and the relationship with systemic and local inflammation].
Zhang J; Yao WZ; Sun YC
Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):356-9. PubMed ID: 18953960
[TBL] [Abstract][Full Text] [Related]
5. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
6. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
7. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
8. Complement in asthma: sensitivity to activation and generation of C3a and C5a via the different complement pathways.
Wust SK; Blumenthal MN; Corazalla EO; Benson BA; Dalmasso AP
Transl Res; 2006 Oct; 148(4):157-63. PubMed ID: 17002917
[TBL] [Abstract][Full Text] [Related]
9. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
Schifferli JA; Steiger G; Paccaud JP
Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
[TBL] [Abstract][Full Text] [Related]
10. Anaphylatoxin levels in human aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
[TBL] [Abstract][Full Text] [Related]
11. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma.
Krug N; Tschernig T; Erpenbeck VJ; Hohlfeld JM; Köhl J
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1841-3. PubMed ID: 11734433
[TBL] [Abstract][Full Text] [Related]
12. [Anaphylatoxins C3a, C4a, C5a].
Fujino S; Mori M; Sakurabayashi I
Nihon Rinsho; 2010 Jun; 68 Suppl 6():82-5. PubMed ID: 20942007
[No Abstract] [Full Text] [Related]
13. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo.
DiScipio RG; Daffern PJ; Jagels MA; Broide DH; Sriramarao P
J Immunol; 1999 Jan; 162(2):1127-36. PubMed ID: 9916743
[TBL] [Abstract][Full Text] [Related]
14. Anaphylatoxins in preterm and term labor.
Soto E; Romero R; Richani K; Espinoza J; Nien JK; Chaiworapongsa T; Santolaya-Forgas J; Edwin SS; Mazor M
J Perinat Med; 2005; 33(4):306-13. PubMed ID: 16207115
[TBL] [Abstract][Full Text] [Related]
15. [Immunological tests: Anaphylatoxins C3a, C4a, C5a].
Fujino S; Sakurabayashi I
Nihon Rinsho; 2005 Jul; 63 Suppl 7():80-3. PubMed ID: 16111194
[No Abstract] [Full Text] [Related]
16. Correlation of plasma complement split product levels with allergic respiratory disease activity and relation to allergen immunotherapy.
Bowser C; Erstein DP; Silverberg JI; Nowakowski M; Joks R
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):42-9. PubMed ID: 20143644
[TBL] [Abstract][Full Text] [Related]
17. Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage.
Mack WJ; Ducruet AF; Hickman ZL; Garrett MC; Albert EJ; Kellner CP; Mocco J; Connolly ES
Neurosurgery; 2007 Aug; 61(2):255-60; discussion 260-1. PubMed ID: 17762737
[TBL] [Abstract][Full Text] [Related]
18. Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg.
Bajic G; Yatime L; Klos A; Andersen GR
Protein Sci; 2013 Feb; 22(2):204-12. PubMed ID: 23184394
[TBL] [Abstract][Full Text] [Related]
19. Unexplained intrauterine fetal death is accompanied by activation of complement.
Richani K; Romero R; Soto E; Espinoza J; Nien JK; Chaiworapongsa T; Refuerzo J; Blackwell S; Edwin SS; Santolaya-Forgas J; Mazor M
J Perinat Med; 2005; 33(4):296-305. PubMed ID: 16207114
[TBL] [Abstract][Full Text] [Related]
20. Complement split products C3a and C4a are early markers of acute lyme disease in tick bite patients in the United States.
Shoemaker RC; Giclas PC; Crowder C; House D; Glovsky MM
Int Arch Allergy Immunol; 2008; 146(3):255-61. PubMed ID: 18270493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]